act-hib 10 mikrog / 0,5 ml injektiokuiva-aine ja liuotin, liuosta varten
sanofi pasteur europe - haemophilus influenzae b polysakkaridi,tetanustoksoidi konjugaatti - injektiokuiva-aine ja liuotin, liuosta varten - 10 mikrog / 0,5 ml - haemophilus influenzae tyyppi b konjugaattirokote
havrix 1440 elisa u/ml injektioneste, suspensio
glaxosmithkline biologicals sa - hepatiitti a-virus, kokovirus, inaktivoitu - injektioneste, suspensio - 1440 elisa u/ml - inaktivoitu hepatiitti a -rokote (koko virus)
typhim vi 25 mikrog / 0.5 ml injektioneste, liuos, esitäytetty ruisku
sanofi pasteur europe - salmonella typhi (ty2) bakteerit, vi polysakkaridi - injektioneste, liuos, esitäytetty ruisku - 25 mikrog / 0.5 ml - lavantautipolysakkaridirokote
nobilis gumboro vet injektioneste, emulsio
intervet international b.v. - avian infectious bursal disease virus, inactivated - injektioneste, emulsio - gumboron tauti -rokote
thalidomide bms (previously thalidomide celgene)
bristol-myers squibb pharma eeig - talidomidin - multiple myeloma - immunosuppressantit - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.
vectibix
amgen europe b.v. - panitumumabista - paksusuolen vajaatoiminta - antineoplastiset aineet - vectibix is indicated for the treatment of adult patients with wild-type ras metastatic colorectal cancer (mcrc): , in first-line in combination with folfox or folfiri. toisen linjan yhdessä folfiri-hoidon kanssa potilailla, jotka ovat saaneet ensilinjan fluoropyrimidiini-pohjaista solunsalpaajahoitoa (ilman irinotekaania). kuin monoterapian jälkeen epäonnistuminen fluoropyrimidiini-, oksaliplatiinia ja irinotekaania sisältävä solunsalpaajahoito.
flexilev 5 mg/1,25 mg dispergoituvat tabletit annostelulaitteeseen
sensidose ab - carbidopa monohydrate, levodopa - dispergoituvat tabletit annostelulaitteeseen - 5 mg/1,25 mg - levodopa ja dekarboksylaasin estäjä
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - hemostaatit - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
thalidomide lipomed
lipomed gmbh - talidomidin - multiple myeloma - immunosuppressantit - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
ethambutol orion 500 mg tabletti
orion corporation - ethambutol dihydrochloride - tabletti - 500 mg - etambutoli